0255 De novo belatacept does not reduce skin cancer incidence or burden in kidney transplant recipients
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S45
DOI: 10.1016/j.jid.2026.06.286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von D.M. Gamada und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gamada, D., Fan, E., Liu, W., Motavaf, M., Chopra, S., Ellis, M., Byrns, J., Liu, B., Green, C., Jew, O., Myers, S., & Whitley, M. J. (2026). 0255 De novo belatacept does not reduce skin cancer incidence or burden in kidney transplant recipients. Journal of Investigative Dermatology, 146(8), S45. https://doi.org/10.1016/j.jid.2026.06.286
Vancouver
Gamada D, Fan E, Liu W, Motavaf M, Chopra S, Ellis M, et al. 0255 De novo belatacept does not reduce skin cancer incidence or burden in kidney transplant recipients. Journal of Investigative Dermatology. 2026;146(8):S45. doi:10.1016/j.jid.2026.06.286
BibTeX
@article{Gamada2026,
author = {Gamada, D.M. and Fan, E. and Liu, W.W. and Motavaf, M. and Chopra, S. and Ellis, M.J. and Byrns, J. and Liu, B. and Green, C. and Jew, O.S. and Myers, S. and Whitley, M. Javid},
title = {0255 De novo belatacept does not reduce skin cancer incidence or burden in kidney transplant recipients},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S45},
doi = {10.1016/j.jid.2026.06.286}
}
EUVIMED